
Sudarshan Pharma Industries Ltd is Rated Sell
2026-04-12 10:10:02Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-04-08 08:04:04Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a strong day gain of 4.69%, the stock’s technical indicators present a mixed picture, reflecting both cautious optimism and lingering bearish undertones. This analysis delves into the recent price action, key technical signals, and comparative performance against the broader market.
Read full news article
Sudarshan Pharma Industries Ltd is Rated Sell
2026-04-01 10:10:03Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 01 April 2026, providing investors with the latest comprehensive analysis.
Read full news article
Sudarshan Pharma Industries Ltd is Rated Sell
2026-03-21 10:10:03Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news article
Sudarshan Pharma Industries Ltd is Rated Sell
2026-03-10 10:10:02Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-03-02 08:02:54Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a strong day gain of 3.61% to close at ₹28.40, the stock’s technical indicators present a nuanced picture, with weekly signals showing mild bullishness while monthly trends lean bearish. This article analyses the recent price action, technical indicator signals, and broader market context to provide a comprehensive view for investors.
Read full news article
Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-02-27 08:02:47Sudarshan Pharma Industries Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong one-month return of 37.5%, the stock’s longer-term performance remains subdued, prompting a cautious outlook from analysts.
Read full news article
Sudarshan Pharma Industries Ltd is Rated Sell
2026-02-26 10:10:03Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most recent insights into the company’s performance and outlook.
Read full news article
Sudarshan Pharma Industries Ltd is Rated Sell
2026-02-15 10:10:07Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Apr-2026 | Source : BSEPlease find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations 2018 received from Kfin Technologies Limited for the quarter ended 31/March/2026.
Closure of Trading Window
30-Mar-2026 | Source : BSEThe Trading Window of the Company shall remain closed with effect from April 1 2026 until the expiry of 48 hours after the declaration of financial results for the quarter and financial year ended 31/March/2026.
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Updates On GST Inspection Search And Seizure
26-Feb-2026 | Source : BSEIn continuation to our letter dated February 22 2026 we hereby inform you that GST inspection search and seizure operation at the registered office of the Company which commenced on February 21 2026 has concluded on February 25 2026.
Corporate Actions
No Upcoming Board Meetings
Sudarshan Pharma Industries Ltd has declared 3% dividend, ex-date: 25 Aug 23
Sudarshan Pharma Industries Ltd has announced 1:10 stock split, ex-date: 22 Nov 24
No Bonus history available
No Rights history available






